Uptake of pneumococcal vaccination in older people in northern Israel
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...
Main Authors: | , |
---|---|
格式: | Article |
語言: | English |
出版: |
Elsevier
2021-12-01
|
叢編: | Preventive Medicine Reports |
主題: | |
在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2211335521002436 |